Prednisone Completed Phase 2 Trials for Untreated T-Cell Angioimmunoblastic Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00169156A Phase II Study of Rituximab Combined With CHOP in T-cell Angio-immunoblastic Lymphoma